GE HealthCare has dosed the first patient in its LUMINA trial for mangaciclanol. Read why this MRI contrast milestone could reshape imaging markets.
Karius and Mayo Clinic Laboratories are expanding access to rapid metagenomic infection tests. Read what this could change for hospital diagnostics.
See how Johnson & Johnson is using CARTOSOUND SONATA and VARIPULSE to reshape electrophysiology workflow and arrhythmia care. Read more.
Artera has won CE marking for its AI prostate and breast cancer assays. Read what this means for oncology diagnostics, adoption, and global expansion.
FDA cleared blood-based collection for SOLVD Health’s AvertD. Find out why this could expand genetic opioid risk testing in surgical care.
Read how Johnson & Johnson’s ETHICON 4000 CE Mark approval could reshape surgical stapling, hospital economics, and future robotic integration.
Hologic’s latest breast imaging AI data suggests stronger detection of hard-to-find cancers. Read what it could mean for screening adoption.
Dana-Farber’s new study highlights Ignite Proteomics in Enhertu response prediction. Read what this could mean for metastatic breast cancer care.
Pulnovo Medical raised $100 million with Medtronic backing. Read what it means for PADN, pulmonary hypertension, heart failure, and device markets.
Bruker expanded its microbiology portfolio at ESCMID 2026. Read what the new MALDI and outbreak tools could mean for labs and infection control.